Klf5, the most downregulated TF, is an active factor associated with miRNAs in cancer and cardiovascular disease (Drosatos et al., 2016; Yang et al., 2018; Nan et al., 2021; Wang Y. et al., 2021). Here, KLF5 is linked to cardiovascular disorder.